CNS Pharmaceuticals Inc Financial Flexibility Index
CNS Pharmaceuticals Inc financial flexibility index. CNS Pharmaceuticals Inc (CNSP) has a Financial Flexibility Index of -0.95x as of June 2026. Free cash flow of $-3.54 Million (operating CF $-3.54 Million minus capex $3.82K) represents -1% of total liabilities ($3.74 Million).
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of CNS Pharmaceuticals Inc (2017–2025)
Financial flexibility index of CNS Pharmaceuticals Inc from 2017 to 2025. Historical Financial Flexibility Index trend for CNS Pharmaceuticals Inc across 9 annual periods. Explore CNS Pharmaceuticals Inc (CNSP) debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
CNS Pharmaceuticals Inc Financial Flexibility Index by Year (2017–2025)
CNS Pharmaceuticals Inc financial flexibility index by year from 2017 to 2025. Year-by-year free cash flow to debt coverage for CNS Pharmaceuticals Inc. For the full cash flow conversion analysis, see cash efficiency ratio of CNS Pharmaceuticals Inc.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -3.36x | $-13.79 Million | $-13.81 Million | $4.10 Million | ▲ +50.4% |
| 2024 | -6.78x | $-17.11 Million | $-17.11 Million | $2.52 Million | ▼ -194.0% |
| 2023 | -2.30x | $-14.14 Million | $-14.14 Million | $6.13 Million | ▼ -7.5% |
| 2022 | -2.14x | $-10.55 Million | $-10.56 Million | $4.92 Million | ▲ +66.2% |
| 2021 | -6.34x | $-13.53 Million | $-13.54 Million | $2.14 Million | ▼ -65.4% |
| 2020 | -3.83x | $-7.30 Million | $-7.32 Million | $1.91 Million | ▲ +66.3% |
| 2019 | -11.36x | $-3.53 Million | $-3.55 Million | $311.00K | ▼ -1854.9% |
| 2018 | -0.58x | $-716.38K | $-716.38K | $1.23 Million | ▼ -14.3% |
| 2017 | -0.51x | $-112.19K | $-112.20K | $220.73K | — |